Sanofi on Pace for Highest Close Since April 2023 — Data Talk
Sanofi Sponsored ADR (SNY) is currently at $55.96, up $0.73 or 1.32%
--Would be highest close since April 27, 2023, when it closed at $56.09
--On pace for largest percent increase since Aug. 13, 2024, when it rose 2.68%
--Currently up eight of the past nine days
--Currently up seven consecutive days; up 4.54% over this period
--Longest winning streak since July 21, 2023, when it rose for eight straight trading days
--Best seven day stretch since the seven days ending July 25, 2024, when it rose 6.09%
--Up 8.01% month-to-date; on pace for best month since March 2023, when it rose 16.16%
--Up 12.53% year-to-date
--Down 2.61% from its all-time closing high of $57.46 on April 11, 2022
--Up 4.75% from 52 weeks ago (Aug. 25, 2023), when it closed at $53.42
--Would be a new 52-week closing high
--Up 29.75% from its 52-week closing low of $43.13 on Oct. 27, 2023
--Traded as high as $56.18; highest intraday level since April 27, 2023, when it hit $56.26
--Up 1.72% at today's intraday high; largest intraday percent increase since Aug. 13, 2024, when it rose as much as 2.68%
All data as of 12:05:06 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 23, 2024 12:25 ET (16:25 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks